1. A comprehensively characterized large panel of head and neck cancer patient‐derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option. Issue 12 (26th November 2014) Authors: Klinghammer, Konrad; Raguse, Jan‐Dirk; Plath, Thomas; Albers, Andreas E.; Joehrens, Korinna; Zakarneh, Andre; Brzezicha, Bernadette; Wulf‐Goldenberg, Annika; Keilholz, Ulrich; Hoffmann, Jens; Fichtner, Iduna Journal: International journal of cancer Issue: Volume 136:Issue 12(2015:Jun. 15) Page Start: 2940 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB‐552 in mouse models. (20th July 2014) Authors: Vallespí, Maribel G.; Pimentel, Gilmara; Cabrales‐Rico, Ania; Garza, Julio; Oliva, Brizaida; Mendoza, Osmani; Gomez, Yolanda; Basaco, Tais; Sánchez, Iraida; Calderón, Carlos; Rodriguez, Juan C.; Markelova, Maria Rivera; Fichtner, Iduna; Astrada, Soledad; Bollati‐Fogolín, Mariela; Garay, Hilda E.;... Journal: Journal of peptide science Issue: Volume 20:Number 11(2014:Nov.) Page Start: 850 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Basal subtype is predictive for response to cetuximab treatment in patient‐derived xenografts of squamous cell head and neck cancer. Issue 6 (21st June 2017) Authors: Klinghammer, Konrad; Otto, Raik; Raguse, Jan‐Dirk; Albers, Andreas E.; Tinhofer, Ingeborg; Fichtner, Iduna; Leser, Ulf; Keilholz, Ulrich; Hoffmann, Jens Journal: International journal of cancer Issue: Volume 141:Issue 6(2017:Sep. 15) Page Start: 1215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Improving the transport of chemotherapeutic drugs across the blood–brain barrier. Issue 4 (July 2011) Authors: Orthmann, Andrea; Fichtner, Iduna; Zeisig, Reiner Journal: Expert review of clinical pharmacology Issue: Volume 4:Issue 4(2011) Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Improving the transport of chemotherapeutic drugs across the blood––brain barrier. Issue 4 (July 2011) Authors: Orthmann, Andrea; Fichtner, Iduna; Zeisig, Reiner Journal: Expert review of clinical pharmacology Issue: Volume 4:Issue 4(2011) Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Mutation-specific effects of NRAS oncogenes in colorectal cancer cells. (January 2021) Authors: Kuhn, Natalia; Klinger, Bertram; Uhlitz, Florian; Sieber, Anja; Rivera, Maria; Klotz-Noack, Kathleen; Fichtner, Iduna; Hoffmann, Jens; Blüthgen, Nils; Falk, Christine; Sers, Christine; Schäfer, Reinhold Journal: Advances in biological regulation Issue: Volume 79(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. New Wnt/β-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals. Issue 10 (8th July 2015) Authors: Qi, Jingjing; Yu, Yong; Akilli Öztürk, Özlem; Holland, Jane D; Besser, Daniel; Fritzmann, Johannes; Wulf-Goldenberg, Annika; Eckert, Klaus; Fichtner, Iduna; Birchmeier, Walter Journal: Gut Issue: Volume 65:Issue 10(2016) Page Start: 1690 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacologic activity and pharmacokinetics of metabolites of regorafenib in preclinical models. (13th October 2016) Authors: Zopf, Dieter; Fichtner, Iduna; Bhargava, Ajay; Steinke, Wolfram; Thierauch, Karl‐Heinz; Diefenbach, Konstanze; Wilhelm, Scott; Hafner, Frank‐Thorsten; Gerisch, Michael Journal: Cancer medicine Issue: Volume 5:Number 11(2016:Nov.) Page Start: 3176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Preclinical study on combined chemo‐ and nonviral gene therapy for sensitization of melanoma using a human TNF‐alpha expressing MIDGE DNA vector. Issue 3 (18th January 2014) Authors: Kobelt, Dennis; Aumann, Jutta; Schmidt, Manuel; Wittig, Burghardt; Fichtner, Iduna; Behrens, Diana; Lemm, Margit; Freundt, Greta; Schlag, Peter M.; Walther, Wolfgang Journal: Molecular oncology Issue: Volume 8:Issue 3(2014:May) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Preclinical study on combined chemo‐ and nonviral gene therapy for sensitization of melanoma using a human TNF‐alpha expressing MIDGE DNA vector1. Issue 3 (18th January 2014) Authors: Kobelt, Dennis; Aumann, Jutta; Schmidt, Manuel; Wittig, Burghardt; Fichtner, Iduna; Behrens, Diana; Lemm, Margit; Freundt, Greta; Schlag, Peter M.; Walther, Wolfgang Journal: Molecular oncology Issue: Volume 8:Issue 3(2014:May) Page Start: 609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗